Intrust Bank NA Has $441,000 Stake in STERIS plc (NYSE:STE)

Intrust Bank NA reduced its holdings in STERIS plc (NYSE:STE) by 19.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,147 shares of the medical equipment provider’s stock after selling 507 shares during the quarter. Intrust Bank NA’s holdings in STERIS were worth $441,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank bought a new stake in shares of STERIS in the 4th quarter valued at about $238,836,000. Raymond James Financial Inc. acquired a new stake in STERIS in the fourth quarter worth $223,987,000. Franklin Resources Inc. boosted its position in shares of STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after purchasing an additional 529,308 shares in the last quarter. Boston Trust Walden Corp grew its holdings in shares of STERIS by 400.4% in the 4th quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider’s stock valued at $46,198,000 after buying an additional 179,829 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in STERIS by 15.9% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,261,927 shares of the medical equipment provider’s stock worth $257,585,000 after buying an additional 172,795 shares during the period. 94.69% of the stock is owned by institutional investors.

STERIS Stock Performance

Shares of STERIS stock opened at $222.99 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The firm has a market cap of $21.91 billion, a price-to-earnings ratio of 47.34 and a beta of 0.92. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The stock’s 50-day moving average is $222.51 and its 200-day moving average is $221.15.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.02%. STERIS’s payout ratio is currently 48.41%.

Analyst Upgrades and Downgrades

STE has been the subject of a number of research analyst reports. Stephens reissued an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler increased their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, STERIS presently has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.